| Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products. | |
| | |
MedLine Citation:
|
PMID: 20589167 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Bone marrow derived stem cells administered after minimal manipulation represent an important cell source for cell-based therapies. Clinical trial results, have revealed both safety and efficacy of the cell reinfusion procedure in many cardiovascular diseases. Many of these early clinical trials were performed in a period before the entry into force of the US and European regulation on cell-based therapies. As a result, conflicting data have been generated on the effectiveness of those therapies in certain conditions as acute myocardial infarction. As more academic medical centers and private companies move toward exploiting the full potential of cell-based medicinal products, needs arise for the development of the infrastructure necessary to support these investigations. This review describes the regulatory environment surrounding the production of cell based medicinal products and give practical aspects for cell isolation, characterization, production following Good Manufacturing Practice, focusing on the activities associated with the investigational new drug development. |
| | |
Authors:
|
Giuseppe Astori; Sabrina Soncin; Viviana Lo Cicero; Francesco Siclari; Daniel Sürder; Lucia Turchetto; Gianni Soldati; Tiziano Moccetti |
Related Documents
:
|
20469427 - Software for family practice: a decade of development. 19665337 - Development and preliminary evaluation of a cognitive behavioural approach to fatigue m... 10174797 - What's wrong with strategy? 11609027 - Development of unani medicine during mughal period. 14652117 - Difficult airway management practice patterns among anesthesiologists practicing in the... 6641077 - In vivo diagnostic nuclear medicine. pediatric experience. |
Publication Detail:
|
Type: Journal Article Date: 2010-05-15 |
Journal Detail:
|
Title: American journal of translational research Volume: 2 ISSN: 1943-8141 ISO Abbreviation: Am J Transl Res Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-06-30 Completed Date: 2010-08-12 Revised Date: 2010-09-30 |
Medline Journal Info:
|
Nlm Unique ID: 101493030 Medline TA: Am J Transl Res Country: United States |
Other Details:
|
Languages: eng Pagination: 285-95 Citation Subset: - |
Affiliation:
|
Cell Therapy Unit, Foundation Cardiocentro Ticino, Via Tesserete 48, CH-6900 Lugano, Switzerland. Giuseppe.Astori@cardiocentro.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Involvement of oxidatively damaged DNA and repair in cancer development and aging.
Next Document: VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial ce...